| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 57.40B | 52.96B | 49.95B | 42.44B | 40.48B |
| Gross Profit | 40.47B | 37.82B | 36.39B | 33.56B | 32.62B |
| EBITDA | 23.91B | 21.39B | 18.74B | 13.53B | 18.41B |
| Net Income | 12.44B | 10.47B | 8.50B | 6.72B | 13.75B |
Balance Sheet | |||||
| Total Assets | 168.36B | 140.98B | 134.38B | 109.30B | 131.11B |
| Cash, Cash Equivalents and Short-Term Investments | 11.20B | 10.66B | 10.19B | 21.90B | 46.55B |
| Total Debt | 104.10B | 94.47B | 90.48B | 75.86B | 84.25B |
| Total Liabilities | 147.39B | 131.74B | 132.83B | 115.06B | 125.16B |
| Stockholders Equity | 20.45B | 8.70B | 1.07B | -6.22B | 5.24B |
Cash Flow | |||||
| Free Cash Flow | -394.00M | 11.81B | 8.47B | 5.03B | 13.75B |
| Operating Cash Flow | 20.82B | 18.67B | 17.16B | 9.54B | 15.89B |
| Investing Cash Flow | -21.71B | -7.36B | -36.48B | 11.22B | -13.10B |
| Financing Cash Flow | 1.10B | -10.55B | 7.91B | -29.13B | -10.38B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $247.96B | 35.15 | 12.18% | 0.63% | 8.41% | 22.92% | |
79 Outperform | $3.60T | 34.64 | 32.24% | 0.71% | 15.59% | 15.89% | |
73 Outperform | $132.07B | 119.32 | 15.33% | ― | 15.30% | -60.71% | |
69 Neutral | $287.36B | 36.38 | 16.30% | 1.07% | 11.85% | 167.23% | |
67 Neutral | $121.80B | -379.01 | -8.88% | ― | 22.05% | -341.24% | |
66 Neutral | $569.97B | 36.71 | 70.60% | 1.00% | 11.08% | 29.56% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
Oracle announced its fiscal 2026 Q2 financial results, reporting a significant increase in remaining performance obligations to $523 billion, up 438% year-over-year. The company’s total quarterly revenues rose by 14% in USD to $16.1 billion, driven by a 34% increase in cloud revenues. Oracle’s strategic shift towards chip neutrality and its focus on embedding AI across its software products are expected to enhance its market position, with its Multicloud database business experiencing rapid growth.
On November 18, 2025, Oracle Corporation’s Board of Directors elected Stephen Rusckowski as a director, expanding the board to 14 members. Rusckowski, with a rich background in healthcare and technology, is expected to provide valuable insights into Oracle Health’s operations. Additionally, Oracle held its 2025 Annual Meeting of Stockholders where directors were elected, executive compensation was approved, and Ernst & Young LLP was ratified as the independent accounting firm for the fiscal year ending May 31, 2026.
On September 26, 2025, Oracle Corporation completed the issuance and sale of $18 billion in aggregate principal amount of notes with varying maturities and interest rates. The proceeds from this issuance are intended for general corporate purposes, including capital expenditures, debt repayment, and potential investments or acquisitions, which could impact Oracle’s financial strategy and market positioning.
On September 22, 2025, Oracle announced significant management changes with the promotion of Clay Magouyrk and Mike Sicilia to Chief Executive Officers, effective immediately. These changes reflect Oracle’s strategic focus on advancing its AI and cloud infrastructure capabilities. Magouyrk, with his experience in Oracle Cloud Infrastructure, and Sicilia, with his expertise in industry applications, are expected to drive Oracle’s growth in the AI era. Safra Catz transitions to Executive Vice Chair of the Board, while Doug Kehring becomes the Principal Financial Officer. These leadership changes aim to position Oracle for continued success in the rapidly evolving technology landscape.